Sign Up: our FREE Website

Sign Up: our FREE Website

Categories

Industry

eResearch is pleased to provide InvestmentPitch's Video-of-the-Day on Canntab Therapeutics Limited. The Company's goal is to become a leader in oral dosage cannabis, with products that offer advantages to the medical community, patients, adult use consumers, and governments. The Company believes that it has a competitive advantage through robust intellectual property with 13 patents pending in the United States and Canada. It has valuable licensing and joint venture deals in Canada and international markets, such as Australia and Mexico. It boasts robust new product development, including 420 therapeutics, with the goal being to establish itself as a leader in the wellness category. Click on Continue reading ---> below to go to the Link that will allow you to access the report.

Continue reading
eResearch is pleased to provide the latest Stock Gumshoe widely-promoted mystery company. Today's article looks at an ad about the “Super Crystal Solar Revolution,” which spools up a big surge of excitement about a new kind of solar cell that will change the world. The teaser ad claims that this under $3 stock will unleash the greatest leap in the history of electricity. This little-known company is right in the middle of what is predicted will be a $134 billion market by 2020. Also, apparently a very big mutual fund has started buying shares of the company. Finally, they have a “secret partnership” with a U.S. company that is teased to be Apple.

Continue reading
eResearch is pleased to publish our Initiating Report on Newgioco Group, Inc. (OTCQB: NWGI). We are Initiating Coverage on Newgioco with a 1-year price target of $1.30. Newgioco is a vertically integrated organization engaged in the leisure gaming (gambling) industry, primarily in Italy but currently expanding worldwide. Newgioco generates revenues from providing retail land-based and web-based gambling products and services in regulated countries and offers solutions for both the Business-to-Business (B2B) and Business-to-Consumers (B2C) markets. The Company's forecasted double-digit growth over the next year, in the Italian retail gaming market, could be accelerated with tactical acquisitions. Over the next several years, Newgioco is poised to capture some of the recently deregulated, multibillion-dollar, U.S. sports betting market through the Company’s proprietary betting platform (ELYS™). We believe that Newgioco is overlooked and undervalued in the market, and it is also trading at a discount to peers.

Continue reading